Lilley Elliot, Isbrucker Richard, Holmes Anthony
NC3Rs, London, United Kingdom.
Health Canada, Ottawa, Canada.
Biologicals. 2025 Feb;89:101778. doi: 10.1016/j.biologicals.2024.101778. Epub 2024 Dec 20.
A recently published report from the UK National Centre for the Replacement, Refinement, and Reduction of Animals in Research (NC3Rs) has highlighted significant opportunities for the broader inclusion of 3Rs approaches (i.e. Replacement, Reduction and Refinement of animal tests) within World Health Organization (WHO) manuals, guidelines and recommendations for vaccines and biotherapeutics. The report is the culmination of a three-year project, co-funded by the Bill & Melinda Gates Foundation, to review the extent to which animal-based testing methods are described in WHO manuals, guidelines and recommendations. The aim was to identify where recommendations did not incorporate current non-animal testing strategies and/or 3Rs principles in biologicals quality control and batch release testing. The inclusion of such methods in WHO guidance documents would improve their adoption by regulators and help to accelerate the safe release of these products to the communities who need them most. The final report was presented to the WHO's Expert Committee on Biological Standardization (ECBS) in October 2023 for their consideration and response. The project findings and recommendations described in the report are summarised in this article.
英国国家动物研究替代、优化与减少中心(NC3Rs)最近发布的一份报告强调,在世界卫生组织(WHO)关于疫苗和生物治疗药物的手册、指南及建议中,更广泛地纳入3R方法(即替代、减少和优化动物试验)存在重大机遇。该报告是一个为期三年项目的成果,该项目由比尔及梅琳达·盖茨基金会共同资助,旨在审查WHO手册、指南和建议中对基于动物的检测方法的描述程度。目的是确定在生物制品质量控制和批次放行检测中,哪些建议未纳入当前的非动物检测策略和/或3R原则。将此类方法纳入WHO指导文件将提高监管机构对它们的采用率,并有助于加速这些产品向最需要它们的社区安全放行。最终报告于2023年10月提交给WHO生物标准化专家委员会(ECBS)以供其审议和回应。本文总结了报告中描述的项目发现和建议。